Comparison of either norepinephrine-uptake inhibitors or phentermine combined with serotonergic agents on food intake in rats

被引:22
作者
Rowland, NE [1 ]
Marshall, M [1 ]
Roth, JD [1 ]
机构
[1] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA
关键词
serotonin; norepinephrine; drug synergy; isobologram; anorectic agent;
D O I
10.1007/s002139900336
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: We have shown previously that the anorectic effects of the catecholamine-releasing agent phentermine (PHEN) and the serotonin (5-HT)-releasing agent dexfenfluramine (DFEN) are greater than additive in rats. In the present study, we examined whether the norepinephrine-uptake inhibitors desmethylimipramine (DMI) and thionisoxetine (TNIX) have additive effects with either DFEN or with the 5-HT-uptake inhibitor fluoxetine (FLX). We also examined whether PHEN interacts with a postsynaptically acting 5-HT agonist. Methods: Undeprived rats were trained to eat a daily sweet-milk dessert and on test days were systemically administered single or combination drugs and the intakes recorded. Results: Both DMI and TNIX produced dose-related suppressions of food intake. However, by isobolographic analysis, they did not enhance the anorectic actions of either DFEN or FLX. In contrast, confirming and extending our previous work, PHEN had a greater potentiating effect on the anorectic actions of DFEN and FLX than TNIX. Further, the anorectic action of the 5-HT2C receptor agonist TFMPP was enhanced by PHEN. Conclusions: These and other data are consistent with the idea that 5-HT agents may work "upstream" of critical catecholaminergic synapses in the production of anorexia, and explain the diminished efficacy of norepinephrine-uptake inhibitors relative to PHEN. The implications for clinically useful anorectic agents are discussed briefly.
引用
收藏
页码:77 / 83
页数:7
相关论文
共 28 条
  • [1] Effects of phentermine on striatal dopamine and serotonin release in conscious rats:: In vivo microdialysis study
    Balcioglu, A
    Wurtman, RJ
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1998, 22 (04) : 325 - 328
  • [2] BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
  • [3] Valvular heart disease associated with fenfluramine-phentermine
    Connolly, HM
    Crary, JL
    McGoon, MD
    Hensrud, DD
    Edwards, BS
    Edwards, WD
    Schaff, HV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (09) : 581 - 588
  • [4] EFFECT OF PROPRANOLOL PHENTOLAMINE AND PIMOZIDE ON DRUG-INDUCED ANOREXIA IN THE MOUSE
    DOBRZANSKI, S
    DOGGETT, NS
    [J]. PSYCHOPHARMACOLOGY, 1979, 66 (03) : 297 - 300
  • [5] Gehlert DR, 1998, J PHARMACOL EXP THER, V287, P122
  • [6] (R)-THIONISOXETINE, A POTENT AND SELECTIVE INHIBITOR OF CENTRAL AND PERIPHERAL NOREPINEPHRINE UPTAKE
    GEHLERT, DR
    HEMRICKLUECKE, SK
    SCHOBER, DA
    KRUSHINSKI, J
    HOWBERT, JJ
    ROBERTSON, DW
    WONG, DT
    FULLER, RW
    [J]. LIFE SCIENCES, 1995, 56 (22) : 1915 - 1920
  • [7] COMPARISON OF BEHAVIOR MAINTAINED BY INFUSIONS OF 8 PHENYLETHYLAMINES IN BABOONS
    GRIFFITHS, RR
    WINGER, G
    BRADY, JV
    SNELL, JD
    [J]. PSYCHOPHARMACOLOGY, 1976, 50 (03) : 251 - 258
  • [8] Heal DJ, 1998, INT J OBESITY, V22, pS18
  • [9] A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents
    Heal, DJ
    Cheetham, SC
    Prow, MR
    Martin, KF
    Buckett, WR
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (02) : 301 - 308
  • [10] ROLES OF MONOAMINE NEURAL SYSTEMS IN ANOREXIA INDUCED BY (+)-AMPHETAMINE AND RELATED COMPOUNDS
    HOLLISTER, AS
    ERVIN, GN
    COOPER, BR
    BREESE, GR
    [J]. NEUROPHARMACOLOGY, 1975, 14 (10) : 715 - 723